Presented by: The Magni Group, Inc. Jan 2018 Michael Yanez, Dir. Business Dev. The Magni, Group, Inc. Lindsay Rohnke, President The Magni Group, Inc.
THE MAGNI GROUP, INC. • Family owned and operated in Texas, USA • Over 35 years in business, beginning with mail order and direct response advertising • 14 successful items at all major Food, Drug and Mass Merchandise retailers, beginning in 2006 • Prepared for continued increase in retail/club distribution 2
WHY MAGNI LIFE? 1. Successful business model Items are tested in mail-order catalogs/direct response Successful items are expanded to retail Items are fully supported by company advertising 2. Advertising, advertising, advertising $30 million ad spend in 2017 in the US Last minute, remnant space Advertorial style ads drive retail sales Direct response component allows money to roll back into ad budget 3. Consumers love us Great products Effective No side effects 3
MAGNI LIFE GROWTH Annual Retail Sales in Million USD $17.6MM $16.4MM $15.9MM $15.4MM 2015 2016 2017 2018 2014 2015 2016 2017 *on pace *projected *Projected *Projected 4
PRODUCT PORTFOLIO • • • Internal Analgesics Diabetes Skin Care • • • External Analgesics Sleep Incontinence 5 • • • Foot Care Cough/Cold First Aid
PRODUCT HIGHLIGHTS • # 1 item in diabetic and footcare categories • Relieves foot pain along with burning and tingling sensations • Soothes dry, itchy and sensitive skin • Unique item for sciatica pain in the lower back, buttocks and legs • Tablets dissolve under the tongue • $4 Million USD annual sales • New Skincare line tested and ready to launch 2018 6
MagniLife • #1 foot cream in Drug • Began expansion into Food and Mass in 2017 • Expecting continued growth and awareness of brand and category Annual Unit Projection: XXXX Annual $ Projection: $XXXX Pain Relieving Foot Cream – 4 oz. Projected Profit: $XXXX Relieves shooting, stabbing, burning pains and tingling sensations while intense moisturizing treatment softens hardened, callused skin to eliminate painful cracks and dry, itchy skin. Cost: TBD MSRP: $19.99 GM: Top 3 IRI Foot Care Spots 2017 • Ended Year with top 3 IRI Data: 52 weeks, total Drug, ending 1/16/18 selling Foot Care sku’s • (doesn’t include antifungal or insoles which are in different category) Ad Budget - Advertorial style print ads, FSIs, social media, TV (new for 2018) 2016: $28MM 2017: $30MM 2018: $32MM (projected) Ads run on a remnant basis, approximately 40 weeks out of the year, totaling 1.2 billion in annual printed circulation tagging retailers
ADVERTISING PLAN Budget - Advertorial style print ads and FSIs 2014: $23MM* 2015: $25MM* 2016: $28MM* 2017: $30MM* projected *rate card values 8
THE FACTS Overall Numbers, Diabetes and Prediabetes Homeopathic Medicine & Products Market on a Favorable Growth Curve Recent estimates indicate that one in three U.S. children born in 2000 will develop diabetes. Projected growth of 18.2% from 2016-2024 Prevalence : In 2015, 30.3 million Americans, or 9.4% $3.86BN Calculated US Market Sales in 2015: of the population, had diabetes. with dramatic increases predicated as these Approximately 1.25 million American children and products can be safely used with other drugs adults have type 1 diabetes. Today 35% of those who suffer ailments used Undiagnosed : Of the 30.3 million adults with diabetes, a homeopathic product 23.1 million were diagnosed, and 7.2 million were undiagnosed. Prevalence in Seniors : The percentage of Americans age 65 and older remains high, at 25.2%, or 12.0 million seniors (diagnosed and undiagnosed). New Cases : 1.5 million Americans are diagnosed with diabetes every year. Prediabetes : In 2015, 84.1 million Americans age 18 and older had prediabetes. 9
COMPANY CONTACTS The Magni Group, Inc. 7106 Wellington Point Road McKinney, TX 75070 USA +1 972-540-2050 www.MagniLife.com Michael Yanez, Dir. Of Business Dev. myanez@magnico.com Lindsay Rohnke, President LROHNKE@MAGNICO.COM 10
Recommend
More recommend
